» Articles » PMID: 31011288

Dynamic Profile of CD4 T-Cell-Associated Cytokines/Chemokines Following Murine Myocardial Infarction/Reperfusion

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2019 Apr 24
PMID 31011288
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

CD4 T-cells play crucial roles in the injured heart. However, the way in which different CD4 T subtypes function in the myocardial infarction/reperfusion (MI/R) heart is still poorly understood. We aimed to detect the dynamic profile of distinct CD4 subpopulation-associated cytokines/chemokines by relying on a closed-chest acute murine MI/R model. The protein levels of 26 CD4 T-cell-associated cytokines/chemokines were detected in the heart tissues and serum of mice at day 7 and day 14 post-MI/R or sham surgery. The mRNA levels of IL-4, IL-6, IL-13, IL-27, MIP-1, MCP-3, and GRO- were measured in blood mononuclear cells. The protein levels of IL-4, IL-6, IL-13, IL-27, MIP-1, MCP-3, and GRO- increased in both injured heart tissues and serum, while IFN-, IL-12P70, IL-2, IL-1, IL-18, TNF-, IL-5, IL-9, IL-17A, IL-23, IL-10, eotaxin, MIP-1, RANTES, MCP-1, and MIP-2 increased only in MI/R heart tissues in the day 7 and day 14 groups compared to the sham group. In serum, the IFN-, IL-23, and IL-10 levels were downregulated in the MI/R model at both day 7 and day 14 compared to the sham. Compared with the protein expressions in injured heart tissues at day 7, IFN-, IL-12P70, IL-2, IL-18, TNF-, IL-6, IL-4, IL-5, IL-9, IL-17A, IL-23, IL-27, IL-10, eotaxin, IP-10, RANTES, MCP-1, MCP-3, and GRO- were reduced, while IL-1 and MIP-2 were elevated at day 14. IL-13 and MIP-1 showed higher levels in the MI/R serum at day 14 than at day 7. mRNA levels of IL-4, IL-6, IL-13, and IL-27 were increased in the day 7 group compared to the sham, while MIP-1, MCP-3, and GRO- mRNA levels showed no significant difference between the MI/R and sham groups in blood mononuclear cells. Multiple CD4 T-cell-associated cytokines/chemokines were upregulated in the MI/R hearts at the chronic stage. These results provided important evidence necessary for developing future immunomodulatory therapies after MI/R.

Citing Articles

CCL11 (Eotaxin) Promotes the Advancement of Aging-Related Cardiovascular Diseases.

Zhang T, Huang Y, Ji X, Wu T, Xiao P Rev Cardiovasc Med. 2025; 26(2):26020.

PMID: 40026499 PMC: 11868897. DOI: 10.31083/RCM26020.


The Role of Inflammation in the Pathogenesis of Cardiogenic Shock Secondary to Acute Myocardial Infarction: A Narrative Review.

Kologrivova I, Kercheva M, Panteleev O, Ryabov V Biomedicines. 2024; 12(9).

PMID: 39335587 PMC: 11428626. DOI: 10.3390/biomedicines12092073.


Causal effects of inflammatory cytokines on cardiovascular diseases: Insights from genetic evidence.

Chen Y, Zhong A Heliyon. 2024; 10(15):e35447.

PMID: 39165962 PMC: 11334864. DOI: 10.1016/j.heliyon.2024.e35447.


Association of IL13 polymorphisms with susceptibility to myocardial infarction: A case-control study in Chinese population.

Chen R, Bao Q, Ma X PLoS One. 2024; 19(8):e0308081.

PMID: 39088580 PMC: 11293651. DOI: 10.1371/journal.pone.0308081.


The roles of Th cells in myocardial infarction.

Liu J, Liu F, Liang T, Zhou Y, Su X, Li X Cell Death Discov. 2024; 10(1):287.

PMID: 38879568 PMC: 11180143. DOI: 10.1038/s41420-024-02064-6.


References
1.
Veldhoen M, Uyttenhove C, Van Snick J, Helmby H, Westendorf A, Buer J . Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol. 2008; 9(12):1341-6. DOI: 10.1038/ni.1659. View

2.
Raphael I, Nalawade S, Eagar T, Forsthuber T . T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2014; 74(1):5-17. PMC: 4416069. DOI: 10.1016/j.cyto.2014.09.011. View

3.
Markowski P, Boehm O, Goelz L, Haesner A, Ehrentraut H, Bauerfeld K . Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation. Basic Res Cardiol. 2013; 108(5):376. PMC: 3778842. DOI: 10.1007/s00395-013-0376-7. View

4.
Lopez A, Mathers C, Ezzati M, Jamison D, Murray C . Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006; 367(9524):1747-57. DOI: 10.1016/S0140-6736(06)68770-9. View

5.
Hofmann U, Beyersdorf N, Weirather J, Podolskaya A, Bauersachs J, Ertl G . Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation. 2012; 125(13):1652-63. DOI: 10.1161/CIRCULATIONAHA.111.044164. View